Kin Man Au

13PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityNanomaterialsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 06, 2024
Intratumoral Injectable Redox-Responsive Immune Niche Improves the Abscopal Effect in Radiotherapy.

Kin Man Au, J Steven Swinnea, Andrew Z Wang

|May 27, 2024
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles".

Kin Man Au, Rod Balhorn, Monique C Balhorn

|Dec 04, 2023
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.

Kin Man Au, Justin E Wilson, Jenny P-Y Ting

|Nov 29, 2021
In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus.

Kin Man Au, Roland Tisch, Andrew Z Wang

|Nov 14, 2021
Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.

Kin Man Au, Roland Tisch, Andrew Z Wang

|May 08, 2021
Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes.

Kin Man Au, Yusra Medik, Qi Ke

Pageof 3

Frequent Collaborators

7 joint publications

Andrew Z Wang

3 joint publications

Steven I Park

2 joint publications

Seungpyo Hong

1 joint publications

Yuanzeng Min